Elevance Health (ELV) Fell Amid Healthcare Sector Downturn
Key takeaways
- Improving market breadth was noted in the first quarter, but geopolitical instability in the Middle East disrupted this trend.
- In its first-quarter 2026 investor letter, Heartland Opportunistic Value Equity Strategy highlighted stocks such as Elevance Health, Inc.
- Heartland Opportunistic Value Equity Strategy stated the following regarding Elevance Health, Inc.
Elevance Health (ELV) Fell Amid Healthcare Sector Downturn Soumya Eswaran Mon, June 29, 2026 at 8:42 PM GMT+7 3 min read ELV CL=F Heartland Advisors, an investment management company, released its first-quarter 2026 investor letter for the "Heartland Opportunistic Value Equity Strategy". A copy of the letter can be downloaded here. Improving market breadth was noted in the first quarter, but geopolitical instability in the Middle East disrupted this trend. Instead of speculating on the conflict's duration or crude oil prices, we focus on bottom-up fundamental analysis. The market also favored AI winners with high valuations and penalized losers. Against this backdrop, the strategy appreciated 3.66%, outperforming the Russell 3000 Value Index, which rose 2.23%. Stock selection was positive across most sectors. In addition, you can check the Fund's top 5 holdings to determine its best picks for 2026.
In its first-quarter 2026 investor letter, Heartland Opportunistic Value Equity Strategy highlighted stocks such as Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is a health benefits company that detracted from the Strategy's performance in the quarter. On June 26, 2026, Elevance Health, Inc. (NYSE:ELV) closed at $395.18 per share, reflecting a market capitalization of $85.81 billion. Elevance Health, Inc. (NYSE:ELV) posted a one-month return of -1.86%, while its shares gained 1.60% over the past 52 weeks.
Heartland Opportunistic Value Equity Strategy stated the following regarding Elevance Health, Inc. (NYSE:ELV) in its Q1 2026 investor letter: